Abstract:Objective To develop a new statistical method for comparing effectiveness of two treatments for the same disease indication.A statistical method needs to be developed to compare effectiveness of different treatments by using existing clinical data when lacking of evidence from randomized controlled trials.Methods Datasets including an outcome variable and a confounder for two treatments were simulated.Subjects in each dataset were randomly divided into two arms for 100 times,and the means were compared by using student-t tests and Per-protocol analysis strategy was applied.Subjects with assigned treatment by randomization that was contradictory to the actual received treatment were considered drop-out of conventional RCTs,and were excluded from comparisons of means.The ratio of the frequency of hypothesis tests that rejected H0 to the frequency of hypothesis tests that did not reject H0,called odds,was used to predict the probability of significant tests for group difference.To document the consistency and reliability of the method,the distribution of odds and its 95% CI,and the confounding effect were described in simulated datasets with various between-group mean differences and statistical power(ranging from 0.5 to 0.85) with varied sample sizes(n=50,100,500,and 1 000).Stata 11.0 was used to program and perform the analysis.Results The odds and its 95%CI of simulated RCTs were perfectly and linearly correlated with the change of between-group mean differences and statistical power,by difference sample size.A conclusion could be made based on the hypothesis of the simulated randomized controlled trials(sRCT).The probability of loss of balance of confounding was over 95% for equal and unequal sample size of two arms after excluding misclassified subjects.Conclusions The proposed novel analytical method,simulated RCTs based on real clinical treatment data,can be used to compare effectiveness of two treatments when evidence from RCTs is unavailable.

Statistical Methods for Non-inferiority Testing in Active-controlled Clinical Trials

Method of Control Selection and Margin Choice in Non-Inferiority Trials

Tests of Noninferiority Via Rate Difference for Three-Arm Clinical Trials with Placebo.

A Quantitative Bias Analysis to Assess Constancy Assumption in Noninferiority Trials Using Bayesian Hierarchical Models

Dealing with Non-inferiority Test in Multicenter Trials

Testing Non-Inferiority of a New Treatment in Three-Arm Clinical Trials with Binary Endpoints

A novel statistical method for comparing effectiveness of two treatments-simulated randomized controlled trials

Exploring Statistical Methods in Clinical Trials When Some of the Patients are Treated against the Randomization

Non-inferiority and networks: inferring efficacy from a web of data

Active Control Trials - Hypotheses and Issues*

A Direct Approach to Simultaneous Tests of Superiority and Noninferiority with Multiple Endpoints

Statistical Analysis of Noninferiority Trials with a Rate Ratio in Small-Sample Matched-Pair Designs.

A More Efficient Three-Arm Non-Inferiority Test Based on Pooled Estimators of the Homogeneous Variance.

APPLICATION OF NON-INFERIORITY ANALYSIS METHODS IN ONCOLOGY NDA*

Some Statistical Issues of Confirming Efficacy in Clinical Trials

Non-Parametric Non-Inferiority Assessment in a Three-Arm Trial with Non-Ignorable Missing Data

Systematic Evaluation of Non-Inferiority and Equivalence Randomized Trials of Anti-Infective Drugs

A non-inferiority test of areas under two parametric ROC curves

Two New Methods for Non-Inferiority Testing of the Ratio in Matched-Pair Setting

Semiparametric Bayesian Approach to Assess Non-Inferiority with Assay Sensitivity in a Three-Arm Trial with Normally Distributed Endpoints

Assessing non-inferiority with time-to-event data via the method of non-parametric covariance.